Discover REAC ACT treatments, a breakthrough non-invasive therapy developed by the Rinaldi Fontani Institute. Scientifically proven to reduce inflammation, regenerate tissue, and improve skin health, REAC ACT is the future of aesthetic and wellness medicine.

In recent years, advances in reparative and regenerative medicine have led to the development of innovative technologies for skin care and overall wellness. Among these, the REAC Anti-inflammatory Anti-Cellulite (ACT) treatments stand out for their cutting-edge approach in countering silent chronic inflammation and improving the quality of connective tissue. These therapeutic interventions, made possible exclusively by the Radio Electric Asymmetric Conveyer (REAC) technology developed by the Rinaldi Fontani Institute, represent a significant advancement in the fields of wellness, aesthetics, and longevity.
Cellulite is a very common condition, characterized by alterations in microcirculation, connective tissue structure, and subcutaneous fat distribution. However, more than a mere cosmetic concern, it often results from low-grade inflammatory processes that impair tissue function and accelerate skin degeneration.
Silent chronic inflammation, although asymptomatic, plays a key role in the progression of cellulite and the loss of skin tone. This form of inflammation disrupts cellular balance, compromises collagen quality, and reduces the connective tissue’s ability to maintain its structure. As a result, the skin appears less firm, circulation diminishes, and fluid and toxin retention mechanisms are triggered.
REAC ACT treatments utilize asymmetrically conveyed radio electric fields—exclusive to REAC technology—to specifically modulate the cellular processes responsible for inflammation and tissue degeneration. Unlike other approaches that merely address the symptoms of cellulite using mechanical or pharmacological methods, REAC ACT treatments work at a deeper level by rebalancing the bioelectrical activity of affected cells.
This endogenous bioelectrical modulation targets fibroblasts—the cells responsible for producing collagen and elastin. The result is a reduction in tissue inflammation, improved blood and lymphatic circulation, and progressive regeneration of connective tissue.
Scientific evidence supports the benefits of REAC ACT treatment, highlighting its impact on specific cellular biomarkers associated with skin aging and health.
One of the most innovative aspects of REAC ACT treatments is their non-invasive nature. Unlike methods involving chemical substances, lasers, or aggressive mechanical manipulation, REAC ACT treatments work without altering skin physiology. Their action is gradual and progressive, leading to visible improvements in skin quality and the reduction of subcutaneous tissue alterations.
Thanks to their deep and targeted effects, REAC ACT treatments do more than improve the aesthetic appearance of the skin—they address the biological mechanisms underlying skin degeneration. This makes them an ideal therapeutic option not only for individuals seeking to reduce cellulite, but also for those interested in a comprehensive approach to skin health and longevity.
The Rinaldi Fontani Institute is a center of excellence in the research and development of advanced therapeutic solutions based on REAC technology. The creation of treatments such as REAC ACT is the result of decades of study in reparative and regenerative medicine and neuromodulation, aimed at providing safe, effective, and scientifically supported therapies.
The exclusivity of REAC technology ensures an action that no other method can replicate, making REAC ACT treatments a benchmark solution for those seeking an innovative approach to skin care and overall tissue wellness, including anti-aging benefits.
REAC ACT treatments represent a true revolution in the fields of wellness, aesthetics, and longevity, combining science and innovation to improve skin health and counter the inflammatory processes underlying cellulite and many other conditions. By rebalancing cellular mechanisms and repairing connective tissue, these treatments offer a cutting-edge solution for individuals seeking healthier, firmer, and more radiant skin, with long-term benefits for overall wellness.
The non-invasive and scientifically validated nature of REAC ACT treatments makes them an ideal choice for those who wish to care for their skin in an effective, safe, and lasting way—enhancing not only appearance but also quality of life and cellular longevity.
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V